Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer


GÜNEŞ M., Gecit I., Pirincci N., Kemik A. S., Purisa S., Ceylan K., ...Daha Fazla

Journal of Cancer Research and Clinical Oncology, cilt.139, sa.2, ss.195-199, 2013 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 139 Sayı: 2
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00432-012-1305-0
  • Dergi Adı: Journal of Cancer Research and Clinical Oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.195-199
  • Anahtar Kelimeler: Bladder cancer, Clinicopathological parameters, Human neutrophil proteins-1,-2, and-3
  • Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

Objectives: Human neutrophil proteins-1, -2, and -3 (HNPs -1, -2, and -3) are expressed in several tumor types. However, the role of HNPs 1-3 in human bladder cancer has not yet been determined. We investigated the association between the plasma levels of HNPs 1-3 and clinicopathological parameters in bladder cancer patients. Design and methods: The plasma levels of HNPs 1-3 were measured in 60 patients with bladder cancer and in 58 healthy controls. The plasma levels of HNPs 1-3 were determined by a solid-phase enzyme-linked immunosorbent assay (ELISA). Plasma samples were obtained before surgery. Plasma samples were permitted to clot and were then stored at -80 C until use. Results: The levels of the HNPs increased from grade 1 to 4 tumors and this difference was statistically significant (p < 0.001). Additionally, plasma HNP levels were significantly higher in patients with metastatic bladder cancer and in patients with lymphovascular involvement, metastasis of the lymph nodes, and increased tumor burden (p < 0.001). Conclusions: The preoperative plasma levels of HNPs 1-3 paralleled the progression and pathological stages of the malignancies. This study suggests that HNPs 1-3 promote tumor invasion and are potential indicators of disease progression in patients with bladder cancer. © 2012 Springer-Verlag Berlin Heidelberg.